A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 [clinicaltrials:NCT00000949]
A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 [clinicaltrials:NCT00000949]
Bio2RDF identifier
NCT00000949
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00000949
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... in the blood (viral burden).
brief title [clinicaltrials_vocabulary:brief-title]
A Study to Evaluate the Effect ...... nts Greater Than 300 Cells/mm3
completion date [clinicaltrials_vocabulary:completion-date]
2000-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
There is substantial ev ...... rollment of the last patient.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
AIDS-Related Opportunistic Infections
Adolescent Behavior
Anti-HIV Agents
CD4 Lymphocyte Count
Dose-Response Relationship, Drug
Interleukin-2
Quality of Life
RNA, Viral
Viral Load
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-09-28T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00000949
official title [clinicaltrials_vocabulary:official-title]
A Randomized, Open-Label, Stud ...... eater Than or Equal to 300/mm3
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-09-01T00:00:00Z
identifier
clinicaltrials:NCT00000949
title
A Study to Evaluate the Effect ...... nts Greater Than 300 Cells/mm3
@en
type
label
A Study to Evaluate the Effect ...... 3 [clinicaltrials:NCT00000949]
@en